nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—SLCO1B3—Olmesartan—hypertension	0.0361	0.0595	CbGbCtD
Dabrafenib—SLCO1B3—Telmisartan—hypertension	0.0289	0.0476	CbGbCtD
Dabrafenib—SLCO1B3—Valsartan—hypertension	0.0281	0.0463	CbGbCtD
Dabrafenib—SLCO1B1—Olmesartan—hypertension	0.021	0.0347	CbGbCtD
Dabrafenib—SLCO1B3—Atorvastatin—hypertension	0.0177	0.0291	CbGbCtD
Dabrafenib—SLCO1B1—Valsartan—hypertension	0.0164	0.027	CbGbCtD
Dabrafenib—SLC22A6—Chlorothiazide—hypertension	0.0163	0.0269	CbGbCtD
Dabrafenib—SLC22A6—Ethacrynic acid—hypertension	0.0163	0.0269	CbGbCtD
Dabrafenib—SLCO1B3—Losartan—hypertension	0.0161	0.0266	CbGbCtD
Dabrafenib—SLC22A8—Enalapril—hypertension	0.0147	0.0243	CbGbCtD
Dabrafenib—SLC22A8—Bumetanide—hypertension	0.0137	0.0226	CbGbCtD
Dabrafenib—ABCG2—Telmisartan—hypertension	0.0134	0.022	CbGbCtD
Dabrafenib—ABCG2—Prazosin—hypertension	0.0121	0.0199	CbGbCtD
Dabrafenib—CYP2C8—Torasemide—hypertension	0.0107	0.0177	CbGbCtD
Dabrafenib—SLCO1B1—Atorvastatin—hypertension	0.0103	0.0169	CbGbCtD
Dabrafenib—SLC22A6—Enalapril—hypertension	0.0103	0.0169	CbGbCtD
Dabrafenib—CYP2C8—Candesartan—hypertension	0.00999	0.0165	CbGbCtD
Dabrafenib—SLC22A6—Hydrochlorothiazide—hypertension	0.00978	0.0161	CbGbCtD
Dabrafenib—SLC22A6—Bumetanide—hypertension	0.00958	0.0158	CbGbCtD
Dabrafenib—SLCO1B1—Losartan—hypertension	0.0094	0.0155	CbGbCtD
Dabrafenib—SLC22A8—Furosemide—hypertension	0.00886	0.0146	CbGbCtD
Dabrafenib—SLCO1B1—Verapamil—hypertension	0.0083	0.0137	CbGbCtD
Dabrafenib—ABCB1—Nadolol—hypertension	0.00796	0.0131	CbGbCtD
Dabrafenib—SLC22A6—Captopril—hypertension	0.00768	0.0126	CbGbCtD
Dabrafenib—CYP2C8—Diltiazem—hypertension	0.00757	0.0125	CbGbCtD
Dabrafenib—ABCB1—Acebutolol—hypertension	0.00728	0.012	CbGbCtD
Dabrafenib—ABCB1—Metoprolol—hypertension	0.00676	0.0111	CbGbCtD
Dabrafenib—ABCB1—Candesartan—hypertension	0.00676	0.0111	CbGbCtD
Dabrafenib—ABCG2—Verapamil—hypertension	0.00659	0.0109	CbGbCtD
Dabrafenib—ABCB1—Terazosin—hypertension	0.00636	0.0105	CbGbCtD
Dabrafenib—CYP3A4—Guanethidine—hypertension	0.00629	0.0104	CbGbCtD
Dabrafenib—CYP2C8—Irbesartan—hypertension	0.00617	0.0102	CbGbCtD
Dabrafenib—SLC22A6—Furosemide—hypertension	0.00617	0.0102	CbGbCtD
Dabrafenib—CYP2C8—Amlodipine—hypertension	0.00605	0.00998	CbGbCtD
Dabrafenib—SLC22A6—Losartan—hypertension	0.00604	0.00996	CbGbCtD
Dabrafenib—ABCB1—Reserpine—hypertension	0.00603	0.00993	CbGbCtD
Dabrafenib—CYP2C8—Spironolactone—hypertension	0.00594	0.00979	CbGbCtD
Dabrafenib—CYP2C8—Felodipine—hypertension	0.00584	0.00962	CbGbCtD
Dabrafenib—CYP2C8—Nifedipine—hypertension	0.00565	0.0093	CbGbCtD
Dabrafenib—CYP2C8—Nicardipine—hypertension	0.00556	0.00916	CbGbCtD
Dabrafenib—ABCB1—Perindopril—hypertension	0.00551	0.00909	CbGbCtD
Dabrafenib—ABCB1—Doxazosin—hypertension	0.00531	0.00875	CbGbCtD
Dabrafenib—ABCB1—Nisoldipine—hypertension	0.00531	0.00875	CbGbCtD
Dabrafenib—ABCB1—Diltiazem—hypertension	0.00513	0.00845	CbGbCtD
Dabrafenib—ABCB1—Telmisartan—hypertension	0.00482	0.00794	CbGbCtD
Dabrafenib—CYP3A4—Hydralazine—hypertension	0.00477	0.00785	CbGbCtD
Dabrafenib—ABCB1—Bepridil—hypertension	0.00457	0.00753	CbGbCtD
Dabrafenib—ABCB1—Lisinopril—hypertension	0.00457	0.00753	CbGbCtD
Dabrafenib—ABCB1—Enalapril—hypertension	0.00457	0.00753	CbGbCtD
Dabrafenib—ABCB1—Prazosin—hypertension	0.00436	0.00718	CbGbCtD
Dabrafenib—CYP2C8—Atorvastatin—hypertension	0.00435	0.00717	CbGbCtD
Dabrafenib—ABCB1—Amlodipine—hypertension	0.0041	0.00675	CbGbCtD
Dabrafenib—CYP3A4—Guanfacine—hypertension	0.00405	0.00668	CbGbCtD
Dabrafenib—ABCB1—Spironolactone—hypertension	0.00402	0.00663	CbGbCtD
Dabrafenib—CYP2C8—Losartan—hypertension	0.00398	0.00655	CbGbCtD
Dabrafenib—ABCB1—Felodipine—hypertension	0.00395	0.00651	CbGbCtD
Dabrafenib—ABCB1—Timolol—hypertension	0.00389	0.0064	CbGbCtD
Dabrafenib—ABCB1—Nifedipine—hypertension	0.00382	0.0063	CbGbCtD
Dabrafenib—ABCB1—Nicardipine—hypertension	0.00376	0.0062	CbGbCtD
Dabrafenib—ABCB1—Carvedilol—hypertension	0.00376	0.0062	CbGbCtD
Dabrafenib—CYP3A4—Isradipine—hypertension	0.00361	0.00595	CbGbCtD
Dabrafenib—CYP2C8—Verapamil—hypertension	0.00351	0.00578	CbGbCtD
Dabrafenib—ABCB1—Propranolol—hypertension	0.00346	0.00571	CbGbCtD
Dabrafenib—ABCB1—Captopril—hypertension	0.00342	0.00564	CbGbCtD
Dabrafenib—ABCB1—Clonidine—hypertension	0.0033	0.00544	CbGbCtD
Dabrafenib—CYP3A4—Nisoldipine—hypertension	0.00318	0.00524	CbGbCtD
Dabrafenib—CYP3A4—Indapamide—hypertension	0.00318	0.00524	CbGbCtD
Dabrafenib—CYP3A4—Eplerenone—hypertension	0.00307	0.00506	CbGbCtD
Dabrafenib—CYP3A4—Diltiazem—hypertension	0.00307	0.00506	CbGbCtD
Dabrafenib—ABCB1—Atorvastatin—hypertension	0.00294	0.00485	CbGbCtD
Dabrafenib—CYP3A4—Enalapril—hypertension	0.00274	0.00451	CbGbCtD
Dabrafenib—ABCB1—Losartan—hypertension	0.00269	0.00444	CbGbCtD
Dabrafenib—CYP3A4—Irbesartan—hypertension	0.0025	0.00413	CbGbCtD
Dabrafenib—CYP3A4—Amlodipine—hypertension	0.00246	0.00405	CbGbCtD
Dabrafenib—ABCB1—Verapamil—hypertension	0.00238	0.00392	CbGbCtD
Dabrafenib—CYP3A4—Felodipine—hypertension	0.00237	0.0039	CbGbCtD
Dabrafenib—CYP3A4—Nifedipine—hypertension	0.00229	0.00377	CbGbCtD
Dabrafenib—CYP3A4—Nicardipine—hypertension	0.00225	0.00371	CbGbCtD
Dabrafenib—CYP3A4—Carvedilol—hypertension	0.00225	0.00371	CbGbCtD
Dabrafenib—CYP3A4—Propranolol—hypertension	0.00207	0.00342	CbGbCtD
Dabrafenib—SLC22A8—nephron—hypertension	0.00205	0.0452	CbGeAlD
Dabrafenib—NEK11—medulla oblongata—hypertension	0.00199	0.0437	CbGeAlD
Dabrafenib—CYP3A4—Clonidine—hypertension	0.00198	0.00326	CbGbCtD
Dabrafenib—NEK11—adrenal gland—hypertension	0.00184	0.0405	CbGeAlD
Dabrafenib—CYP3A4—Atorvastatin—hypertension	0.00176	0.00291	CbGbCtD
Dabrafenib—LIMK1—heart—hypertension	0.00176	0.0388	CbGeAlD
Dabrafenib—LIMK1—decidua—hypertension	0.00172	0.0378	CbGeAlD
Dabrafenib—SLC22A8—urine—hypertension	0.00165	0.0363	CbGeAlD
Dabrafenib—CYP3A4—Losartan—hypertension	0.00161	0.00266	CbGbCtD
Dabrafenib—CYP3A4—Verapamil—hypertension	0.00142	0.00235	CbGbCtD
Dabrafenib—SIK1—cardiac ventricle—hypertension	0.00139	0.0306	CbGeAlD
Dabrafenib—LIMK1—adrenal gland—hypertension	0.00132	0.029	CbGeAlD
Dabrafenib—SIK1—myocardium—hypertension	0.00131	0.0288	CbGeAlD
Dabrafenib—RAF1—cardiac ventricle—hypertension	0.00111	0.0243	CbGeAlD
Dabrafenib—BRAF—heart—hypertension	0.00109	0.024	CbGeAlD
Dabrafenib—RAF1—myocardium—hypertension	0.00104	0.0229	CbGeAlD
Dabrafenib—SIK1—nephron tubule—hypertension	0.000958	0.0211	CbGeAlD
Dabrafenib—SIK1—heart—hypertension	0.000912	0.0201	CbGeAlD
Dabrafenib—SIK1—decidua—hypertension	0.000887	0.0195	CbGeAlD
Dabrafenib—SIK1—kidney—hypertension	0.000842	0.0185	CbGeAlD
Dabrafenib—RAF1—brainstem—hypertension	0.00084	0.0185	CbGeAlD
Dabrafenib—SIK1—cortex of kidney—hypertension	0.00082	0.0181	CbGeAlD
Dabrafenib—CYP3A4—urine—hypertension	0.000817	0.018	CbGeAlD
Dabrafenib—BRAF—adrenal gland—hypertension	0.000813	0.0179	CbGeAlD
Dabrafenib—SIK1—cardiac atrium—hypertension	0.00078	0.0172	CbGeAlD
Dabrafenib—RAF1—nephron tubule—hypertension	0.000763	0.0168	CbGeAlD
Dabrafenib—RAF1—adrenal cortex—hypertension	0.000751	0.0165	CbGeAlD
Dabrafenib—SLC22A6—nephron tubule—hypertension	0.000741	0.0163	CbGeAlD
Dabrafenib—SIK1—medulla oblongata—hypertension	0.000735	0.0162	CbGeAlD
Dabrafenib—RAF1—heart—hypertension	0.000726	0.016	CbGeAlD
Dabrafenib—RAF1—smooth muscle tissue—hypertension	0.00072	0.0159	CbGeAlD
Dabrafenib—RAF1—decidua—hypertension	0.000706	0.0155	CbGeAlD
Dabrafenib—RAF1—cardiovascular system—hypertension	0.000685	0.0151	CbGeAlD
Dabrafenib—SIK1—adrenal gland—hypertension	0.000681	0.015	CbGeAlD
Dabrafenib—RAF1—kidney—hypertension	0.00067	0.0148	CbGeAlD
Dabrafenib—RAF1—cortex of kidney—hypertension	0.000653	0.0144	CbGeAlD
Dabrafenib—SLC22A6—cortex of kidney—hypertension	0.000634	0.014	CbGeAlD
Dabrafenib—RAF1—cardiac atrium—hypertension	0.000621	0.0137	CbGeAlD
Dabrafenib—SLCO1B3—endocrine gland—hypertension	0.000608	0.0134	CbGeAlD
Dabrafenib—SIK1—endocrine gland—hypertension	0.00059	0.013	CbGeAlD
Dabrafenib—RAF1—medulla oblongata—hypertension	0.000585	0.0129	CbGeAlD
Dabrafenib—RAF1—adrenal gland—hypertension	0.000542	0.0119	CbGeAlD
Dabrafenib—SIK1—central nervous system—hypertension	0.000532	0.0117	CbGeAlD
Dabrafenib—SLCO1B1—kidney—hypertension	0.000502	0.011	CbGeAlD
Dabrafenib—RAF1—endocrine gland—hypertension	0.00047	0.0103	CbGeAlD
Dabrafenib—SLC22A8—nephron tubule—hypertension	0.000443	0.00976	CbGeAlD
Dabrafenib—RAF1—central nervous system—hypertension	0.000423	0.00932	CbGeAlD
Dabrafenib—SLC22A8—kidney—hypertension	0.00039	0.00858	CbGeAlD
Dabrafenib—SLC22A8—cortex of kidney—hypertension	0.00038	0.00835	CbGeAlD
Dabrafenib—SLCO1B1—endocrine gland—hypertension	0.000352	0.00774	CbGeAlD
Dabrafenib—ABCG2—nephron tubule—hypertension	0.000316	0.00694	CbGeAlD
Dabrafenib—ABCB1—blood vessel—hypertension	0.000313	0.00689	CbGeAlD
Dabrafenib—ABCG2—adrenal cortex—hypertension	0.000311	0.00684	CbGeAlD
Dabrafenib—ABCG2—heart—hypertension	0.0003	0.00661	CbGeAlD
Dabrafenib—ABCG2—decidua—hypertension	0.000292	0.00643	CbGeAlD
Dabrafenib—CYP2C8—kidney—hypertension	0.000285	0.00628	CbGeAlD
Dabrafenib—SLC22A8—central nervous system—hypertension	0.000246	0.00542	CbGeAlD
Dabrafenib—ABCG2—medulla oblongata—hypertension	0.000242	0.00533	CbGeAlD
Dabrafenib—ABCG2—adrenal gland—hypertension	0.000224	0.00493	CbGeAlD
Dabrafenib—CYP2C8—endocrine gland—hypertension	0.0002	0.0044	CbGeAlD
Dabrafenib—CYP3A4—kidney—hypertension	0.000193	0.00425	CbGeAlD
Dabrafenib—ABCB1—nephron tubule—hypertension	0.000156	0.00342	CbGeAlD
Dabrafenib—ABCB1—adrenal cortex—hypertension	0.000153	0.00337	CbGeAlD
Dabrafenib—ABCB1—heart—hypertension	0.000148	0.00326	CbGeAlD
Dabrafenib—ABCB1—decidua—hypertension	0.000144	0.00317	CbGeAlD
Dabrafenib—ABCB1—cardiovascular system—hypertension	0.00014	0.00308	CbGeAlD
Dabrafenib—ABCB1—kidney—hypertension	0.000137	0.00301	CbGeAlD
Dabrafenib—CYP3A4—endocrine gland—hypertension	0.000135	0.00298	CbGeAlD
Dabrafenib—ABCB1—cortex of kidney—hypertension	0.000133	0.00293	CbGeAlD
Dabrafenib—CYP3A4—central nervous system—hypertension	0.000122	0.00269	CbGeAlD
Dabrafenib—ABCB1—medulla oblongata—hypertension	0.000119	0.00263	CbGeAlD
Dabrafenib—ABCB1—adrenal gland—hypertension	0.000111	0.00243	CbGeAlD
Dabrafenib—ABCB1—endocrine gland—hypertension	9.59e-05	0.00211	CbGeAlD
Dabrafenib—ABCB1—central nervous system—hypertension	8.64e-05	0.0019	CbGeAlD
Dabrafenib—Hypersensitivity—Clonidine—hypertension	3.64e-05	0.000176	CcSEcCtD
Dabrafenib—Abdominal pain—Captopril—hypertension	3.64e-05	0.000176	CcSEcCtD
Dabrafenib—Body temperature increased—Captopril—hypertension	3.64e-05	0.000176	CcSEcCtD
Dabrafenib—Headache—Carvedilol—hypertension	3.64e-05	0.000176	CcSEcCtD
Dabrafenib—Rash—Doxazosin—hypertension	3.62e-05	0.000175	CcSEcCtD
Dabrafenib—Fatigue—Losartan—hypertension	3.61e-05	0.000175	CcSEcCtD
Dabrafenib—Dermatitis—Doxazosin—hypertension	3.61e-05	0.000175	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Hydrochlorothiazide—hypertension	3.61e-05	0.000175	CcSEcCtD
Dabrafenib—Vomiting—Fosinopril—hypertension	3.6e-05	0.000174	CcSEcCtD
Dabrafenib—Nausea—Propranolol—hypertension	3.6e-05	0.000174	CcSEcCtD
Dabrafenib—Oedema—Ramipril—hypertension	3.6e-05	0.000174	CcSEcCtD
Dabrafenib—Headache—Doxazosin—hypertension	3.59e-05	0.000174	CcSEcCtD
Dabrafenib—Dry mouth—Timolol—hypertension	3.59e-05	0.000173	CcSEcCtD
Dabrafenib—Constipation—Losartan—hypertension	3.59e-05	0.000173	CcSEcCtD
Dabrafenib—Vomiting—Eplerenone—hypertension	3.58e-05	0.000173	CcSEcCtD
Dabrafenib—Leukopenia—Lisinopril—hypertension	3.58e-05	0.000173	CcSEcCtD
Dabrafenib—Rash—Fosinopril—hypertension	3.57e-05	0.000173	CcSEcCtD
Dabrafenib—Dermatitis—Fosinopril—hypertension	3.57e-05	0.000173	CcSEcCtD
Dabrafenib—Vomiting—Nifedipine—hypertension	3.56e-05	0.000172	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Furosemide—hypertension	3.55e-05	0.000172	CcSEcCtD
Dabrafenib—Rash—Eplerenone—hypertension	3.55e-05	0.000172	CcSEcCtD
Dabrafenib—Headache—Fosinopril—hypertension	3.55e-05	0.000172	CcSEcCtD
Dabrafenib—Hypersensitivity—Trandolapril—hypertension	3.55e-05	0.000172	CcSEcCtD
Dabrafenib—Dermatitis—Eplerenone—hypertension	3.55e-05	0.000172	CcSEcCtD
Dabrafenib—Diarrhoea—Valsartan—hypertension	3.55e-05	0.000172	CcSEcCtD
Dabrafenib—Asthenia—Clonidine—hypertension	3.55e-05	0.000171	CcSEcCtD
Dabrafenib—Vomiting—Verapamil—hypertension	3.54e-05	0.000171	CcSEcCtD
Dabrafenib—Hypersensitivity—Enalapril—hypertension	3.54e-05	0.000171	CcSEcCtD
Dabrafenib—Body temperature increased—Perindopril—hypertension	3.53e-05	0.000171	CcSEcCtD
Dabrafenib—Abdominal pain—Perindopril—hypertension	3.53e-05	0.000171	CcSEcCtD
Dabrafenib—Diarrhoea—Olmesartan—hypertension	3.53e-05	0.000171	CcSEcCtD
Dabrafenib—Headache—Eplerenone—hypertension	3.53e-05	0.000171	CcSEcCtD
Dabrafenib—Rash—Nifedipine—hypertension	3.53e-05	0.000171	CcSEcCtD
Dabrafenib—Nervous system disorder—Ramipril—hypertension	3.53e-05	0.000171	CcSEcCtD
Dabrafenib—Dermatitis—Nifedipine—hypertension	3.52e-05	0.00017	CcSEcCtD
Dabrafenib—Body temperature increased—Irbesartan—hypertension	3.52e-05	0.00017	CcSEcCtD
Dabrafenib—Abdominal pain—Irbesartan—hypertension	3.52e-05	0.00017	CcSEcCtD
Dabrafenib—Thrombocytopenia—Ramipril—hypertension	3.52e-05	0.00017	CcSEcCtD
Dabrafenib—Oedema—Timolol—hypertension	3.51e-05	0.00017	CcSEcCtD
Dabrafenib—Rash—Verapamil—hypertension	3.51e-05	0.00017	CcSEcCtD
Dabrafenib—Dermatitis—Verapamil—hypertension	3.51e-05	0.00017	CcSEcCtD
Dabrafenib—Headache—Nifedipine—hypertension	3.5e-05	0.000169	CcSEcCtD
Dabrafenib—Pruritus—Clonidine—hypertension	3.5e-05	0.000169	CcSEcCtD
Dabrafenib—Abdominal pain—Hydrochlorothiazide—hypertension	3.49e-05	0.000169	CcSEcCtD
Dabrafenib—Body temperature increased—Hydrochlorothiazide—hypertension	3.49e-05	0.000169	CcSEcCtD
Dabrafenib—Skin disorder—Ramipril—hypertension	3.49e-05	0.000169	CcSEcCtD
Dabrafenib—Infection—Timolol—hypertension	3.49e-05	0.000169	CcSEcCtD
Dabrafenib—Headache—Verapamil—hypertension	3.49e-05	0.000169	CcSEcCtD
Dabrafenib—Hypersensitivity—Telmisartan—hypertension	3.49e-05	0.000169	CcSEcCtD
Dabrafenib—Cough—Lisinopril—hypertension	3.49e-05	0.000169	CcSEcCtD
Dabrafenib—Nausea—Diltiazem—hypertension	3.48e-05	0.000168	CcSEcCtD
Dabrafenib—Nausea—Indapamide—hypertension	3.48e-05	0.000168	CcSEcCtD
Dabrafenib—Hyperhidrosis—Ramipril—hypertension	3.48e-05	0.000168	CcSEcCtD
Dabrafenib—Asthenia—Trandolapril—hypertension	3.46e-05	0.000167	CcSEcCtD
Dabrafenib—Nervous system disorder—Timolol—hypertension	3.45e-05	0.000167	CcSEcCtD
Dabrafenib—Nausea—Carvedilol—hypertension	3.45e-05	0.000167	CcSEcCtD
Dabrafenib—Asthenia—Enalapril—hypertension	3.44e-05	0.000167	CcSEcCtD
Dabrafenib—Body temperature increased—Furosemide—hypertension	3.44e-05	0.000166	CcSEcCtD
Dabrafenib—Abdominal pain—Furosemide—hypertension	3.44e-05	0.000166	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Losartan—hypertension	3.43e-05	0.000166	CcSEcCtD
Dabrafenib—Dizziness—Valsartan—hypertension	3.43e-05	0.000166	CcSEcCtD
Dabrafenib—Skin disorder—Timolol—hypertension	3.41e-05	0.000165	CcSEcCtD
Dabrafenib—Dizziness—Olmesartan—hypertension	3.41e-05	0.000165	CcSEcCtD
Dabrafenib—Pruritus—Trandolapril—hypertension	3.41e-05	0.000165	CcSEcCtD
Dabrafenib—Nausea—Doxazosin—hypertension	3.41e-05	0.000165	CcSEcCtD
Dabrafenib—Arthralgia—Lisinopril—hypertension	3.4e-05	0.000164	CcSEcCtD
Dabrafenib—Myalgia—Lisinopril—hypertension	3.4e-05	0.000164	CcSEcCtD
Dabrafenib—Body temperature increased—Betaxolol—hypertension	3.4e-05	0.000164	CcSEcCtD
Dabrafenib—Hyperhidrosis—Timolol—hypertension	3.4e-05	0.000164	CcSEcCtD
Dabrafenib—Asthenia—Telmisartan—hypertension	3.4e-05	0.000164	CcSEcCtD
Dabrafenib—Pruritus—Enalapril—hypertension	3.4e-05	0.000164	CcSEcCtD
Dabrafenib—Diarrhoea—Clonidine—hypertension	3.38e-05	0.000164	CcSEcCtD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	3.38e-05	0.000163	CcSEcCtD
Dabrafenib—Nausea—Fosinopril—hypertension	3.37e-05	0.000163	CcSEcCtD
Dabrafenib—Hypotension—Ramipril—hypertension	3.36e-05	0.000162	CcSEcCtD
Dabrafenib—Pruritus—Telmisartan—hypertension	3.35e-05	0.000162	CcSEcCtD
Dabrafenib—Nausea—Eplerenone—hypertension	3.35e-05	0.000162	CcSEcCtD
Dabrafenib—Dry mouth—Lisinopril—hypertension	3.33e-05	0.000161	CcSEcCtD
Dabrafenib—Nausea—Nifedipine—hypertension	3.32e-05	0.000161	CcSEcCtD
Dabrafenib—Body temperature increased—Losartan—hypertension	3.31e-05	0.00016	CcSEcCtD
Dabrafenib—Abdominal pain—Losartan—hypertension	3.31e-05	0.00016	CcSEcCtD
Dabrafenib—Nausea—Verapamil—hypertension	3.31e-05	0.00016	CcSEcCtD
Dabrafenib—Asthenia—Captopril—hypertension	3.3e-05	0.00016	CcSEcCtD
Dabrafenib—Diarrhoea—Trandolapril—hypertension	3.3e-05	0.000159	CcSEcCtD
Dabrafenib—Vomiting—Valsartan—hypertension	3.3e-05	0.000159	CcSEcCtD
Dabrafenib—Diarrhoea—Enalapril—hypertension	3.28e-05	0.000159	CcSEcCtD
Dabrafenib—Hypotension—Timolol—hypertension	3.28e-05	0.000159	CcSEcCtD
Dabrafenib—Hypersensitivity—Irbesartan—hypertension	3.28e-05	0.000159	CcSEcCtD
Dabrafenib—Vomiting—Olmesartan—hypertension	3.28e-05	0.000159	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Ramipril—hypertension	3.28e-05	0.000158	CcSEcCtD
Dabrafenib—Rash—Valsartan—hypertension	3.27e-05	0.000158	CcSEcCtD
Dabrafenib—Dizziness—Clonidine—hypertension	3.27e-05	0.000158	CcSEcCtD
Dabrafenib—Dermatitis—Valsartan—hypertension	3.27e-05	0.000158	CcSEcCtD
Dabrafenib—Oedema—Lisinopril—hypertension	3.26e-05	0.000158	CcSEcCtD
Dabrafenib—Pruritus—Captopril—hypertension	3.26e-05	0.000158	CcSEcCtD
Dabrafenib—Hypersensitivity—Hydrochlorothiazide—hypertension	3.26e-05	0.000157	CcSEcCtD
Dabrafenib—Rash—Olmesartan—hypertension	3.25e-05	0.000157	CcSEcCtD
Dabrafenib—Insomnia—Ramipril—hypertension	3.25e-05	0.000157	CcSEcCtD
Dabrafenib—Dermatitis—Olmesartan—hypertension	3.25e-05	0.000157	CcSEcCtD
Dabrafenib—Headache—Valsartan—hypertension	3.25e-05	0.000157	CcSEcCtD
Dabrafenib—Diarrhoea—Telmisartan—hypertension	3.24e-05	0.000157	CcSEcCtD
Dabrafenib—Infection—Lisinopril—hypertension	3.24e-05	0.000157	CcSEcCtD
Dabrafenib—Headache—Olmesartan—hypertension	3.23e-05	0.000156	CcSEcCtD
Dabrafenib—Asthenia—Perindopril—hypertension	3.21e-05	0.000155	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Timolol—hypertension	3.2e-05	0.000155	CcSEcCtD
Dabrafenib—Hypersensitivity—Furosemide—hypertension	3.2e-05	0.000155	CcSEcCtD
Dabrafenib—Asthenia—Irbesartan—hypertension	3.2e-05	0.000155	CcSEcCtD
Dabrafenib—Thrombocytopenia—Lisinopril—hypertension	3.19e-05	0.000154	CcSEcCtD
Dabrafenib—Dizziness—Trandolapril—hypertension	3.19e-05	0.000154	CcSEcCtD
Dabrafenib—Insomnia—Timolol—hypertension	3.18e-05	0.000154	CcSEcCtD
Dabrafenib—Dizziness—Enalapril—hypertension	3.17e-05	0.000154	CcSEcCtD
Dabrafenib—Asthenia—Hydrochlorothiazide—hypertension	3.17e-05	0.000153	CcSEcCtD
Dabrafenib—Hypersensitivity—Betaxolol—hypertension	3.17e-05	0.000153	CcSEcCtD
Dabrafenib—Skin disorder—Lisinopril—hypertension	3.17e-05	0.000153	CcSEcCtD
Dabrafenib—Pruritus—Perindopril—hypertension	3.16e-05	0.000153	CcSEcCtD
Dabrafenib—Pruritus—Irbesartan—hypertension	3.15e-05	0.000152	CcSEcCtD
Dabrafenib—Hyperhidrosis—Lisinopril—hypertension	3.15e-05	0.000152	CcSEcCtD
Dabrafenib—Diarrhoea—Captopril—hypertension	3.15e-05	0.000152	CcSEcCtD
Dabrafenib—Vomiting—Clonidine—hypertension	3.14e-05	0.000152	CcSEcCtD
Dabrafenib—Dizziness—Telmisartan—hypertension	3.13e-05	0.000151	CcSEcCtD
Dabrafenib—Pruritus—Hydrochlorothiazide—hypertension	3.13e-05	0.000151	CcSEcCtD
Dabrafenib—Decreased appetite—Ramipril—hypertension	3.13e-05	0.000151	CcSEcCtD
Dabrafenib—Asthenia—Furosemide—hypertension	3.12e-05	0.000151	CcSEcCtD
Dabrafenib—Rash—Clonidine—hypertension	3.12e-05	0.000151	CcSEcCtD
Dabrafenib—Dermatitis—Clonidine—hypertension	3.11e-05	0.000151	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Ramipril—hypertension	3.1e-05	0.00015	CcSEcCtD
Dabrafenib—Fatigue—Ramipril—hypertension	3.1e-05	0.00015	CcSEcCtD
Dabrafenib—Headache—Clonidine—hypertension	3.1e-05	0.00015	CcSEcCtD
Dabrafenib—Hypersensitivity—Losartan—hypertension	3.09e-05	0.000149	CcSEcCtD
Dabrafenib—Asthenia—Betaxolol—hypertension	3.09e-05	0.000149	CcSEcCtD
Dabrafenib—Nausea—Valsartan—hypertension	3.08e-05	0.000149	CcSEcCtD
Dabrafenib—Pruritus—Furosemide—hypertension	3.07e-05	0.000149	CcSEcCtD
Dabrafenib—Constipation—Ramipril—hypertension	3.07e-05	0.000149	CcSEcCtD
Dabrafenib—Nausea—Olmesartan—hypertension	3.06e-05	0.000148	CcSEcCtD
Dabrafenib—Vomiting—Trandolapril—hypertension	3.06e-05	0.000148	CcSEcCtD
Dabrafenib—Diarrhoea—Perindopril—hypertension	3.06e-05	0.000148	CcSEcCtD
Dabrafenib—Decreased appetite—Timolol—hypertension	3.06e-05	0.000148	CcSEcCtD
Dabrafenib—Vomiting—Enalapril—hypertension	3.05e-05	0.000148	CcSEcCtD
Dabrafenib—Diarrhoea—Irbesartan—hypertension	3.05e-05	0.000147	CcSEcCtD
Dabrafenib—Hypotension—Lisinopril—hypertension	3.05e-05	0.000147	CcSEcCtD
Dabrafenib—Dizziness—Captopril—hypertension	3.04e-05	0.000147	CcSEcCtD
Dabrafenib—Pruritus—Betaxolol—hypertension	3.04e-05	0.000147	CcSEcCtD
Dabrafenib—Rash—Trandolapril—hypertension	3.04e-05	0.000147	CcSEcCtD
Dabrafenib—Dermatitis—Trandolapril—hypertension	3.04e-05	0.000147	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Timolol—hypertension	3.03e-05	0.000147	CcSEcCtD
Dabrafenib—Fatigue—Timolol—hypertension	3.03e-05	0.000147	CcSEcCtD
Dabrafenib—Rash—Enalapril—hypertension	3.03e-05	0.000146	CcSEcCtD
Dabrafenib—Dermatitis—Enalapril—hypertension	3.02e-05	0.000146	CcSEcCtD
Dabrafenib—Diarrhoea—Hydrochlorothiazide—hypertension	3.02e-05	0.000146	CcSEcCtD
Dabrafenib—Headache—Trandolapril—hypertension	3.02e-05	0.000146	CcSEcCtD
Dabrafenib—Vomiting—Telmisartan—hypertension	3.01e-05	0.000146	CcSEcCtD
Dabrafenib—Asthenia—Losartan—hypertension	3.01e-05	0.000145	CcSEcCtD
Dabrafenib—Headache—Enalapril—hypertension	3.01e-05	0.000145	CcSEcCtD
Dabrafenib—Rash—Telmisartan—hypertension	2.99e-05	0.000144	CcSEcCtD
Dabrafenib—Dermatitis—Telmisartan—hypertension	2.98e-05	0.000144	CcSEcCtD
Dabrafenib—Diarrhoea—Furosemide—hypertension	2.97e-05	0.000144	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Lisinopril—hypertension	2.97e-05	0.000144	CcSEcCtD
Dabrafenib—Pruritus—Losartan—hypertension	2.97e-05	0.000143	CcSEcCtD
Dabrafenib—Headache—Telmisartan—hypertension	2.97e-05	0.000143	CcSEcCtD
Dabrafenib—Dizziness—Perindopril—hypertension	2.96e-05	0.000143	CcSEcCtD
Dabrafenib—Insomnia—Lisinopril—hypertension	2.95e-05	0.000143	CcSEcCtD
Dabrafenib—Dizziness—Irbesartan—hypertension	2.95e-05	0.000142	CcSEcCtD
Dabrafenib—Diarrhoea—Betaxolol—hypertension	2.94e-05	0.000142	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Ramipril—hypertension	2.94e-05	0.000142	CcSEcCtD
Dabrafenib—Nausea—Clonidine—hypertension	2.94e-05	0.000142	CcSEcCtD
Dabrafenib—Vomiting—Captopril—hypertension	2.93e-05	0.000142	CcSEcCtD
Dabrafenib—Dizziness—Hydrochlorothiazide—hypertension	2.92e-05	0.000141	CcSEcCtD
Dabrafenib—Rash—Captopril—hypertension	2.9e-05	0.00014	CcSEcCtD
Dabrafenib—Dermatitis—Captopril—hypertension	2.9e-05	0.00014	CcSEcCtD
Dabrafenib—Headache—Captopril—hypertension	2.88e-05	0.000139	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Timolol—hypertension	2.87e-05	0.000139	CcSEcCtD
Dabrafenib—Dizziness—Furosemide—hypertension	2.87e-05	0.000139	CcSEcCtD
Dabrafenib—Diarrhoea—Losartan—hypertension	2.87e-05	0.000139	CcSEcCtD
Dabrafenib—Nausea—Trandolapril—hypertension	2.86e-05	0.000138	CcSEcCtD
Dabrafenib—Nausea—Enalapril—hypertension	2.85e-05	0.000138	CcSEcCtD
Dabrafenib—Dizziness—Betaxolol—hypertension	2.84e-05	0.000138	CcSEcCtD
Dabrafenib—Vomiting—Perindopril—hypertension	2.84e-05	0.000137	CcSEcCtD
Dabrafenib—Abdominal pain—Ramipril—hypertension	2.84e-05	0.000137	CcSEcCtD
Dabrafenib—Body temperature increased—Ramipril—hypertension	2.84e-05	0.000137	CcSEcCtD
Dabrafenib—Decreased appetite—Lisinopril—hypertension	2.83e-05	0.000137	CcSEcCtD
Dabrafenib—Vomiting—Irbesartan—hypertension	2.83e-05	0.000137	CcSEcCtD
Dabrafenib—Rash—Perindopril—hypertension	2.82e-05	0.000136	CcSEcCtD
Dabrafenib—Dermatitis—Perindopril—hypertension	2.82e-05	0.000136	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Lisinopril—hypertension	2.81e-05	0.000136	CcSEcCtD
Dabrafenib—Nausea—Telmisartan—hypertension	2.81e-05	0.000136	CcSEcCtD
Dabrafenib—Fatigue—Lisinopril—hypertension	2.81e-05	0.000136	CcSEcCtD
Dabrafenib—Vomiting—Hydrochlorothiazide—hypertension	2.81e-05	0.000136	CcSEcCtD
Dabrafenib—Rash—Irbesartan—hypertension	2.81e-05	0.000136	CcSEcCtD
Dabrafenib—Dermatitis—Irbesartan—hypertension	2.81e-05	0.000136	CcSEcCtD
Dabrafenib—Headache—Perindopril—hypertension	2.8e-05	0.000135	CcSEcCtD
Dabrafenib—Headache—Irbesartan—hypertension	2.79e-05	0.000135	CcSEcCtD
Dabrafenib—Constipation—Lisinopril—hypertension	2.79e-05	0.000135	CcSEcCtD
Dabrafenib—Rash—Hydrochlorothiazide—hypertension	2.79e-05	0.000135	CcSEcCtD
Dabrafenib—Dermatitis—Hydrochlorothiazide—hypertension	2.78e-05	0.000135	CcSEcCtD
Dabrafenib—Abdominal pain—Timolol—hypertension	2.78e-05	0.000134	CcSEcCtD
Dabrafenib—Body temperature increased—Timolol—hypertension	2.78e-05	0.000134	CcSEcCtD
Dabrafenib—Dizziness—Losartan—hypertension	2.77e-05	0.000134	CcSEcCtD
Dabrafenib—Headache—Hydrochlorothiazide—hypertension	2.77e-05	0.000134	CcSEcCtD
Dabrafenib—Vomiting—Furosemide—hypertension	2.76e-05	0.000134	CcSEcCtD
Dabrafenib—Rash—Furosemide—hypertension	2.74e-05	0.000133	CcSEcCtD
Dabrafenib—Dermatitis—Furosemide—hypertension	2.74e-05	0.000132	CcSEcCtD
Dabrafenib—Vomiting—Betaxolol—hypertension	2.74e-05	0.000132	CcSEcCtD
Dabrafenib—Nausea—Captopril—hypertension	2.73e-05	0.000132	CcSEcCtD
Dabrafenib—Headache—Furosemide—hypertension	2.72e-05	0.000132	CcSEcCtD
Dabrafenib—Rash—Betaxolol—hypertension	2.71e-05	0.000131	CcSEcCtD
Dabrafenib—Dermatitis—Betaxolol—hypertension	2.71e-05	0.000131	CcSEcCtD
Dabrafenib—Headache—Betaxolol—hypertension	2.7e-05	0.00013	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Lisinopril—hypertension	2.67e-05	0.000129	CcSEcCtD
Dabrafenib—Vomiting—Losartan—hypertension	2.67e-05	0.000129	CcSEcCtD
Dabrafenib—Nausea—Perindopril—hypertension	2.66e-05	0.000128	CcSEcCtD
Dabrafenib—Hypersensitivity—Ramipril—hypertension	2.65e-05	0.000128	CcSEcCtD
Dabrafenib—Nausea—Irbesartan—hypertension	2.65e-05	0.000128	CcSEcCtD
Dabrafenib—Rash—Losartan—hypertension	2.64e-05	0.000128	CcSEcCtD
Dabrafenib—Dermatitis—Losartan—hypertension	2.64e-05	0.000128	CcSEcCtD
Dabrafenib—Headache—Losartan—hypertension	2.63e-05	0.000127	CcSEcCtD
Dabrafenib—Nausea—Hydrochlorothiazide—hypertension	2.62e-05	0.000127	CcSEcCtD
Dabrafenib—Hypersensitivity—Timolol—hypertension	2.59e-05	0.000125	CcSEcCtD
Dabrafenib—Nausea—Furosemide—hypertension	2.58e-05	0.000125	CcSEcCtD
Dabrafenib—Asthenia—Ramipril—hypertension	2.58e-05	0.000125	CcSEcCtD
Dabrafenib—Abdominal pain—Lisinopril—hypertension	2.58e-05	0.000125	CcSEcCtD
Dabrafenib—Body temperature increased—Lisinopril—hypertension	2.58e-05	0.000125	CcSEcCtD
Dabrafenib—Nausea—Betaxolol—hypertension	2.56e-05	0.000124	CcSEcCtD
Dabrafenib—Pruritus—Ramipril—hypertension	2.54e-05	0.000123	CcSEcCtD
Dabrafenib—Asthenia—Timolol—hypertension	2.52e-05	0.000122	CcSEcCtD
Dabrafenib—Nausea—Losartan—hypertension	2.49e-05	0.00012	CcSEcCtD
Dabrafenib—Pruritus—Timolol—hypertension	2.49e-05	0.00012	CcSEcCtD
Dabrafenib—Diarrhoea—Ramipril—hypertension	2.46e-05	0.000119	CcSEcCtD
Dabrafenib—Diarrhoea—Timolol—hypertension	2.4e-05	0.000116	CcSEcCtD
Dabrafenib—Hypersensitivity—Lisinopril—hypertension	2.4e-05	0.000116	CcSEcCtD
Dabrafenib—Dizziness—Ramipril—hypertension	2.38e-05	0.000115	CcSEcCtD
Dabrafenib—Asthenia—Lisinopril—hypertension	2.34e-05	0.000113	CcSEcCtD
Dabrafenib—Dizziness—Timolol—hypertension	2.32e-05	0.000112	CcSEcCtD
Dabrafenib—Pruritus—Lisinopril—hypertension	2.31e-05	0.000112	CcSEcCtD
Dabrafenib—Vomiting—Ramipril—hypertension	2.29e-05	0.000111	CcSEcCtD
Dabrafenib—Rash—Ramipril—hypertension	2.27e-05	0.00011	CcSEcCtD
Dabrafenib—Dermatitis—Ramipril—hypertension	2.26e-05	0.00011	CcSEcCtD
Dabrafenib—Headache—Ramipril—hypertension	2.25e-05	0.000109	CcSEcCtD
Dabrafenib—Vomiting—Timolol—hypertension	2.23e-05	0.000108	CcSEcCtD
Dabrafenib—Diarrhoea—Lisinopril—hypertension	2.23e-05	0.000108	CcSEcCtD
Dabrafenib—Rash—Timolol—hypertension	2.22e-05	0.000107	CcSEcCtD
Dabrafenib—Dermatitis—Timolol—hypertension	2.21e-05	0.000107	CcSEcCtD
Dabrafenib—Headache—Timolol—hypertension	2.2e-05	0.000106	CcSEcCtD
Dabrafenib—Dizziness—Lisinopril—hypertension	2.16e-05	0.000104	CcSEcCtD
Dabrafenib—Nausea—Ramipril—hypertension	2.14e-05	0.000103	CcSEcCtD
Dabrafenib—Nausea—Timolol—hypertension	2.09e-05	0.000101	CcSEcCtD
Dabrafenib—Vomiting—Lisinopril—hypertension	2.07e-05	0.0001	CcSEcCtD
Dabrafenib—Rash—Lisinopril—hypertension	2.06e-05	9.94e-05	CcSEcCtD
Dabrafenib—Dermatitis—Lisinopril—hypertension	2.05e-05	9.93e-05	CcSEcCtD
Dabrafenib—Headache—Lisinopril—hypertension	2.04e-05	9.88e-05	CcSEcCtD
Dabrafenib—Nausea—Lisinopril—hypertension	1.94e-05	9.37e-05	CcSEcCtD
Dabrafenib—RAF1—Signaling Pathways—CAV1—hypertension	2.35e-06	1.67e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—APOA1—hypertension	2.35e-06	1.67e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—MTOR—hypertension	2.35e-06	1.67e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL1B—hypertension	2.34e-06	1.66e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—SLC2A4—hypertension	2.34e-06	1.66e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GCG—hypertension	2.34e-06	1.66e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PPARG—hypertension	2.33e-06	1.66e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—KDR—hypertension	2.33e-06	1.65e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PTGS2—hypertension	2.32e-06	1.65e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—SLC2A3—hypertension	2.31e-06	1.64e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ALAS1—hypertension	2.31e-06	1.64e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CYP11B2—hypertension	2.31e-06	1.64e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CTGF—hypertension	2.31e-06	1.64e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—POMC—hypertension	2.3e-06	1.63e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—INS—hypertension	2.29e-06	1.62e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—HMGCR—hypertension	2.29e-06	1.62e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GOT2—hypertension	2.29e-06	1.62e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CXCL8—hypertension	2.28e-06	1.62e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ADA—hypertension	2.28e-06	1.62e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—HSD3B1—hypertension	2.28e-06	1.62e-05	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—EP300—hypertension	2.27e-06	1.61e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GOT1—hypertension	2.26e-06	1.61e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—AQP1—hypertension	2.25e-06	1.6e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—FADS1—hypertension	2.25e-06	1.6e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—ALB—hypertension	2.24e-06	1.59e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PRKCB—hypertension	2.24e-06	1.59e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—F2—hypertension	2.24e-06	1.59e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—FN1—hypertension	2.24e-06	1.59e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ADRA2A—hypertension	2.24e-06	1.59e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CDKN1A—hypertension	2.2e-06	1.56e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—STK11—hypertension	2.2e-06	1.56e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CYP19A1—hypertension	2.2e-06	1.56e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—PTEN—hypertension	2.2e-06	1.56e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NOTCH1—hypertension	2.19e-06	1.56e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CA9—hypertension	2.19e-06	1.55e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—TBXAS1—hypertension	2.19e-06	1.55e-05	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—AKT1—hypertension	2.17e-06	1.54e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PPARG—hypertension	2.16e-06	1.53e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—MAPK8—hypertension	2.15e-06	1.53e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ALOX5AP—hypertension	2.13e-06	1.51e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ALOX15—hypertension	2.13e-06	1.51e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—POMC—hypertension	2.13e-06	1.51e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—INS—hypertension	2.12e-06	1.5e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ALB—hypertension	2.1e-06	1.49e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—EP300—hypertension	2.09e-06	1.49e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—TH—hypertension	2.09e-06	1.49e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CALM2—hypertension	2.09e-06	1.48e-05	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—AKT1—hypertension	2.09e-06	1.48e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—LHB—hypertension	2.08e-06	1.48e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—HADHA—hypertension	2.08e-06	1.48e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MMP9—hypertension	2.06e-06	1.47e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hypertension	2.06e-06	1.47e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CDKN1A—hypertension	2.06e-06	1.46e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—PTEN—hypertension	2.05e-06	1.46e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—COMT—hypertension	2.04e-06	1.45e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—POMC—hypertension	2.04e-06	1.45e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—SLC2A4—hypertension	2.04e-06	1.45e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GCG—hypertension	2.04e-06	1.45e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—SRC—hypertension	2.04e-06	1.45e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—CDKN1A—hypertension	2.03e-06	1.44e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—HSD3B2—hypertension	2.03e-06	1.44e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—LPA—hypertension	2.03e-06	1.44e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—KCNJ11—hypertension	2.03e-06	1.44e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—INS—hypertension	2.03e-06	1.44e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PTEN—hypertension	2.03e-06	1.44e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PPARGC1A—hypertension	2.02e-06	1.43e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GNB3—hypertension	2.02e-06	1.43e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MAPK8—hypertension	2.01e-06	1.43e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—HMOX1—hypertension	2.01e-06	1.42e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PIK3R1—hypertension	2.01e-06	1.42e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—NOS3—hypertension	2.01e-06	1.42e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCL2—hypertension	2e-06	1.42e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CAT—hypertension	1.98e-06	1.41e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GOT1—hypertension	1.97e-06	1.4e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hypertension	1.97e-06	1.4e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IGF1—hypertension	1.96e-06	1.39e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GNAS—hypertension	1.96e-06	1.39e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—AKT2—hypertension	1.96e-06	1.39e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—EP300—hypertension	1.96e-06	1.39e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—EGFR—hypertension	1.95e-06	1.39e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—LRP2—hypertension	1.95e-06	1.38e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CYP2C18—hypertension	1.95e-06	1.38e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ALB—hypertension	1.94e-06	1.38e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—EP300—hypertension	1.93e-06	1.37e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—APOB—hypertension	1.92e-06	1.36e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CYP19A1—hypertension	1.92e-06	1.36e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—STK11—hypertension	1.92e-06	1.36e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—SRC—hypertension	1.9e-06	1.35e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—SRC—hypertension	1.88e-06	1.34e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—HSPG2—hypertension	1.87e-06	1.33e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GSTM1—hypertension	1.87e-06	1.33e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—SERPINE1—hypertension	1.86e-06	1.32e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—NOS3—hypertension	1.86e-06	1.32e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PIK3R1—hypertension	1.86e-06	1.32e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—VEGFA—hypertension	1.85e-06	1.32e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—LPL—hypertension	1.83e-06	1.3e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PTGS2—hypertension	1.83e-06	1.3e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—IL6—hypertension	1.83e-06	1.3e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ALOX5—hypertension	1.81e-06	1.29e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GLP1R—hypertension	1.81e-06	1.29e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—FGF2—hypertension	1.8e-06	1.28e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—RHOA—hypertension	1.8e-06	1.28e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ADCY5—hypertension	1.8e-06	1.28e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GPX1—hypertension	1.79e-06	1.27e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—EGFR—hypertension	1.78e-06	1.27e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—COMT—hypertension	1.78e-06	1.26e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PIK3R1—hypertension	1.78e-06	1.26e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NOS3—hypertension	1.78e-06	1.26e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PRKCA—hypertension	1.77e-06	1.26e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CYP1A1—hypertension	1.77e-06	1.26e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PPARGC1A—hypertension	1.76e-06	1.25e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GNB3—hypertension	1.76e-06	1.25e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—HMOX1—hypertension	1.75e-06	1.24e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CD36—hypertension	1.74e-06	1.24e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CAT—hypertension	1.72e-06	1.22e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GNAS—hypertension	1.71e-06	1.21e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MYC—hypertension	1.71e-06	1.21e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TGFB1—hypertension	1.7e-06	1.21e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PTGS2—hypertension	1.7e-06	1.21e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—AKT1—hypertension	1.69e-06	1.2e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—MYC—hypertension	1.68e-06	1.2e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—TGFB1—hypertension	1.68e-06	1.19e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—RELA—hypertension	1.68e-06	1.19e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—APOB—hypertension	1.67e-06	1.19e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—EGFR—hypertension	1.67e-06	1.18e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ALDH2—hypertension	1.66e-06	1.18e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—MTHFR—hypertension	1.65e-06	1.17e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—EGFR—hypertension	1.65e-06	1.17e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MTOR—hypertension	1.64e-06	1.17e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GSTM1—hypertension	1.63e-06	1.16e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PPARA—hypertension	1.62e-06	1.15e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—HBA1—hypertension	1.61e-06	1.15e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CYP11A1—hypertension	1.6e-06	1.14e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PTEN—hypertension	1.6e-06	1.14e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—LPL—hypertension	1.6e-06	1.14e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CXCL8—hypertension	1.58e-06	1.12e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—SLC9A1—hypertension	1.58e-06	1.12e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GSTT1—hypertension	1.58e-06	1.12e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—AGT—hypertension	1.57e-06	1.11e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ADCY5—hypertension	1.56e-06	1.11e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GPX1—hypertension	1.56e-06	1.11e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CETP—hypertension	1.56e-06	1.11e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GCLC—hypertension	1.56e-06	1.11e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CYP1A1—hypertension	1.54e-06	1.1e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PRKCA—hypertension	1.54e-06	1.1e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CALM1—hypertension	1.54e-06	1.1e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—APOE—hypertension	1.54e-06	1.09e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—EP300—hypertension	1.53e-06	1.08e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CAV1—hypertension	1.52e-06	1.08e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—APOA1—hypertension	1.52e-06	1.08e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CD36—hypertension	1.52e-06	1.08e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—IL6—hypertension	1.5e-06	1.07e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CYP17A1—hypertension	1.49e-06	1.06e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PTEN—hypertension	1.48e-06	1.05e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ENO1—hypertension	1.48e-06	1.05e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PTGS1—hypertension	1.48e-06	1.05e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—MTHFR—hypertension	1.44e-06	1.02e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MMP9—hypertension	1.43e-06	1.01e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CDKN1A—hypertension	1.42e-06	1.01e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CTGF—hypertension	1.42e-06	1.01e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PTEN—hypertension	1.42e-06	1.01e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—EP300—hypertension	1.41e-06	1e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PPARA—hypertension	1.41e-06	1e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—HMGCR—hypertension	1.41e-06	1e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GOT2—hypertension	1.41e-06	1e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TP53—hypertension	1.4e-06	9.95e-06	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MAPK8—hypertension	1.39e-06	9.86e-06	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—AKT1—hypertension	1.39e-06	9.84e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ADRA2A—hypertension	1.38e-06	9.79e-06	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—AKT1—hypertension	1.37e-06	9.74e-06	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL6—hypertension	1.37e-06	9.74e-06	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—AGT—hypertension	1.37e-06	9.71e-06	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—EP300—hypertension	1.35e-06	9.62e-06	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CALM1—hypertension	1.34e-06	9.55e-06	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—APOE—hypertension	1.34e-06	9.52e-06	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PPARG—hypertension	1.34e-06	9.51e-06	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CAV1—hypertension	1.33e-06	9.43e-06	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—APOA1—hypertension	1.32e-06	9.41e-06	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—POMC—hypertension	1.32e-06	9.38e-06	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—SRC—hypertension	1.32e-06	9.35e-06	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—INS—hypertension	1.31e-06	9.33e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—TH—hypertension	1.29e-06	9.16e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CALM2—hypertension	1.29e-06	9.13e-06	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—VEGFA—hypertension	1.28e-06	9.11e-06	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IL6—hypertension	1.28e-06	9.1e-06	CbGpPWpGaD
Dabrafenib—RAF1—Disease—IL6—hypertension	1.27e-06	8.99e-06	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—AKT1—hypertension	1.27e-06	8.99e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GCG—hypertension	1.26e-06	8.91e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—SLC2A4—hypertension	1.26e-06	8.91e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GOT1—hypertension	1.22e-06	8.63e-06	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ALB—hypertension	1.2e-06	8.55e-06	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—AKT1—hypertension	1.18e-06	8.4e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—STK11—hypertension	1.18e-06	8.38e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CYP19A1—hypertension	1.18e-06	8.38e-06	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MYC—hypertension	1.18e-06	8.38e-06	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TGFB1—hypertension	1.18e-06	8.36e-06	CbGpPWpGaD
Dabrafenib—RAF1—Disease—AKT1—hypertension	1.17e-06	8.3e-06	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PPARG—hypertension	1.17e-06	8.29e-06	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—EGFR—hypertension	1.15e-06	8.2e-06	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PIK3R1—hypertension	1.15e-06	8.18e-06	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—NOS3—hypertension	1.15e-06	8.18e-06	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—POMC—hypertension	1.15e-06	8.17e-06	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—INS—hypertension	1.14e-06	8.13e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—COMT—hypertension	1.1e-06	7.79e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PPARGC1A—hypertension	1.08e-06	7.68e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GNB3—hypertension	1.08e-06	7.68e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—HMOX1—hypertension	1.08e-06	7.65e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CAT—hypertension	1.06e-06	7.55e-06	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PTGS2—hypertension	1.05e-06	7.48e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GNAS—hypertension	1.05e-06	7.48e-06	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ALB—hypertension	1.05e-06	7.45e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—APOB—hypertension	1.03e-06	7.32e-06	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—NOS3—hypertension	1e-06	7.13e-06	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PIK3R1—hypertension	1e-06	7.13e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GSTM1—hypertension	1e-06	7.13e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—LPL—hypertension	9.85e-07	6.99e-06	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TP53—hypertension	9.69e-07	6.88e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ADCY5—hypertension	9.64e-07	6.85e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GPX1—hypertension	9.61e-07	6.82e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PRKCA—hypertension	9.51e-07	6.75e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CYP1A1—hypertension	9.51e-07	6.75e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CD36—hypertension	9.36e-07	6.65e-06	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—AKT1—hypertension	9.22e-07	6.55e-06	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PTEN—hypertension	9.19e-07	6.53e-06	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PTGS2—hypertension	9.18e-07	6.52e-06	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IL6—hypertension	8.87e-07	6.3e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—MTHFR—hypertension	8.87e-07	6.3e-06	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—EP300—hypertension	8.76e-07	6.22e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PPARA—hypertension	8.7e-07	6.18e-06	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—AKT1—hypertension	8.53e-07	6.06e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—AGT—hypertension	8.43e-07	5.98e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CALM1—hypertension	8.28e-07	5.88e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—APOE—hypertension	8.26e-07	5.86e-06	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—AKT1—hypertension	8.18e-07	5.81e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CAV1—hypertension	8.18e-07	5.81e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—APOA1—hypertension	8.16e-07	5.8e-06	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PTEN—hypertension	8.01e-07	5.69e-06	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—EP300—hypertension	7.64e-07	5.42e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PPARG—hypertension	7.19e-07	5.11e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—POMC—hypertension	7.09e-07	5.04e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—INS—hypertension	7.05e-07	5.01e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ALB—hypertension	6.47e-07	4.59e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PIK3R1—hypertension	6.18e-07	4.39e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—NOS3—hypertension	6.18e-07	4.39e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PTGS2—hypertension	5.66e-07	4.02e-06	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—AKT1—hypertension	5.3e-07	3.76e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PTEN—hypertension	4.93e-07	3.5e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—EP300—hypertension	4.7e-07	3.34e-06	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—AKT1—hypertension	4.61e-07	3.28e-06	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—AKT1—hypertension	2.84e-07	2.02e-06	CbGpPWpGaD
